- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Glenmark Pharma faces a GST demand of ~₹16.05 Cr, plus interest & penalty, for FY20-21 related to a brand sale. The company disputes this, plans to appeal, and states no material financial impact.